Cytochrome P450 2D6 activity in human liver microsomes: Assessment of drug metabolizing enzyme lability as a function of incubation conditions

被引：0
|
作者：
Foti, RS [1 ]
Fisher, MB [1 ]
机构：
[1] Pfizer Inc, Pfizer Global Res & Dev, Discovery Pharmacokinet Dynam & Metab, Groton, CT 06340 USA
来源：
DRUG METABOLISM REVIEWS | 2002年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
204
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] Metabolism of dextromethorphan in human liver microsomes: A rapid HPCL assay to monitor cytochrome P450 2D6 activity
    Vielnascher, E
    Spatzenegger, M
    Mayrhofer, A
    Klinger, P
    Jager, W
    PHARMAZIE, 1996, 51 (08): : 586 - 588
  • [2] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562
  • [3] Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate
    McConnachie, L
    Bodor, M
    Kowdley, K
    Levy, A
    Tung, B
    Thummel, K
    Phillips, B
    Bajpai, M
    Chi, V
    Esmay, JD
    Shen, DA
    Ho, RJY
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (04) : 282 - 297
  • [4] Crystal structure of human cytochrome P450 2D6
    Rowland, P
    Blaney, FE
    Smyth, MG
    Jones, JJ
    Leydon, VR
    Oxbrow, AK
    Lewis, CJ
    Tennant, MG
    Modi, S
    Eggleston, DS
    Chenery, RJ
    Bridges, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 7614 - 7622
  • [5] Effect of Desvenlafaxine on the Cytochrome P450 2D6 Enzyme System
    Preskorn, Sheldon H.
    Nichols, Alice I.
    Paul, Jeffrey
    Patroneva, Albena L.
    Helzner, Eileen C.
    Guico-Pabia, Christine J.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2008, 14 (06) : 368 - 378
  • [6] Allosteric effects of cytochrome P450 reductase on cytochrome P450 2D6
    Roberts, GCK
    Modi, S
    Gilham, DE
    Sutcliffe, MJ
    Lian, LY
    Primrose, WU
    Wolf, CR
    FASEB JOURNAL, 1997, 11 (09): : A789 - A789
  • [7] Prediction of drug metabolism: The case of cytochrome P450 2D6
    Vermeulen, NPE
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (11) : 1227 - 1239
  • [8] Oxidation of histamine H1 antagonist mequitazine is catalysed by cytochrome P450 2D6 in human liver microsomes
    Nakamura, K
    Yokoi, T
    Kodama, T
    Inoue, K
    Nagashima, K
    Shimada, N
    Shimizu, T
    Kamataki, T
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R424 - R424
  • [9] Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes
    Nakamura, K
    Yokoi, T
    Kodama, T
    Inoue, K
    Nagashima, K
    Shimada, N
    Shimizu, T
    Kamataki, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (02): : 437 - 442
  • [10] A refilled substrate model for human cytochrome P450 2D6
    deGroot, MJ
    Bijloo, GJ
    Martens, BJ
    vanAcker, FAA
    Vermeulen, NPE
    CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (01) : 41 - 48
12345